Código QR

Expression of miR-223 to predict outcomes after transcatheter aortic valve implantation

BACKGROUND: Transcatheter aortic valve implantation (TAVI) is an established treatment for aortic stenosis (AS) in patients at increased surgical risk. Up to 29% of patients annually experience major adverse cardiac and cerebrovascular events (MACCE) after TAVI. MicroRNAs (miRNA) are currently widel...

ver descrição completa

Na minha lista:
Principais autores: Ceren Eyileten, Alicja Skrobucha, Miłosz Starczyński, Maria Boszko, Joanna Jarosz-Popek, Alex Fitas, Krzysztof J. Filipiak, Janusz Kochman, Zenon Huczek, Bartosz Rymuza, Radosław Wilimski, Mariusz Kuśmierczyk, Jolanta M. Siller-Matula, Marek Postula, Aleksandra Gąsecka
Formato: Artigo
Idioma:Inglês
Publicado em: Via Medica 2024-02-01
Colecção:Cardiology Journal
Assuntos:
aortic stenosis
transcatheter aortic valve implantation (TAVI)
microRNA
prognosis
Acesso em linha:https://journals.viamedica.pl/cardiology_journal/article/view/88863
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados